Getty Images Renews Official Photography Partnership with NASCAR
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 12 2026
0mins
Should l Buy GETY?
Getty Images announced the renewal of its long-standing partnership with NASCAR, extending its role as NASCAR's Official Photography Partner, a designation it has held since 2006.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GETY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GETY
Wall Street analysts forecast GETY stock price to rise
2 Analyst Rating
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.746
Low
7.00
Averages
7.00
High
7.00
Current: 0.746
Low
7.00
Averages
7.00
High
7.00
About GETY
Getty Images Holdings, Inc. is a global visual content creator and marketplace company. The Company offers a full range of content solutions to meet the needs of any customer around the globe. Through its Getty Images, iStock and Unsplash brands, websites and application programming interfaces (APIs), the Company serves customers and discovers, purchases and shares visual content from photographers and videographers. The Company covers approximately 160,000 news, sport and entertainment events, providing depth and breadth of coverage. The Company also maintains photographic archives in the world with millions of images dating back to the beginning of photography. It works with approximately 557,000 contributors and more than 320 content partners to deliver a range of content. Its Getty Images, iStock, and Unsplash brands categorize its content and services into three categories: Creative, Editorial, and Other. Its Gettyimages.com offers premium creative content and editorial coverage.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CMA in the UK Announces 18 March Deadline for Comments on Remedies in Getty Images/Shutterstock Deal, Including Alternative Options
Deadline for Comments: The UK’s CMA has set a deadline of March 18 for any comments on remedies related to the ongoing investigation.
Focus on Alternative Remedies: The investigation includes considerations for alternative remedies in the context of the case.
See More
UK's CMA Announces Extension of Reference Period for Getty Images/Shutterstock Deal to June 14, 2026
UK's CMA Inquiry Group: The UK's Competition and Markets Authority (CMA) has decided to extend the reference period for its inquiry.
New Deadline: The new deadline for the inquiry has been set to June 14, 2026.
See More
Canva Acquires Startups to Counter Market Challenges
- Acquisition Strategy: Canva's acquisition of startups Cavalry and MangoAI aims to bolster its competitive edge in animation and short video advertising, particularly as Adobe faces market pressures, demonstrating Canva's proactive approach to market changes.
- Technology Integration: Cavalry's animation technology will be integrated into Canva's core products and the Affinity application, enhancing user capabilities in motion graphics while allowing Cavalry to operate independently to meet diverse designer needs.
- Revenue Growth: Canva reported an annualized revenue exceeding $4 billion in 2025, a 36% increase year-over-year, indicating strong growth momentum in a competitive market, despite Adobe's market capitalization reaching $101 billion.
- AI Application Prospects: Canva plans to incorporate MangoAI technology into its Canva Grow advertisement generator, assisting users in analyzing video performance and optimizing content strategies, further enhancing product competitiveness and user experience.
See More
U.S. DOJ Approves Getty Images and Shutterstock Merger
- Merger Approval: The U.S. Department of Justice has approved the $3.7 billion merger proposal between Getty Images and Shutterstock, marking a significant advancement in their global market consolidation that is expected to enhance their competitive positioning.
- Waiting Period Expiration: The applicable waiting period under the Hart-Scott Rodino Act has expired, allowing the two companies to begin merger preparations ahead of the final decision from the UK's Competition and Markets Authority (CMA).
- Market Reaction: Although the merger news initially boosted the stock prices of both companies, Getty Images has now experienced its eighth consecutive day of decline, while Shutterstock's shares have also dipped slightly, indicating market caution regarding the merger's prospects.
- Future Outlook: In a joint statement, both companies expressed optimism regarding the CMA's final decision, hoping it will align with the DOJ and other global regulators, based on the merits of the transaction and market realities.
See More
Getty Images Merger with Shutterstock Cleared by DOJ
- Merger Approval: The U.S. Department of Justice has cleared the merger proposal between Getty Images and Shutterstock, marking a significant step towards resource integration and strengthening financial foundations, which is expected to create more investment opportunities in the future.
- Stock Surge: Following the merger announcement, Getty's stock price soared by 32.96% to 98 cents per share, reflecting strong market optimism about the merger's prospects and potentially attracting more investor interest.
- Expected Synergies: The companies anticipate achieving substantial synergies in sales, general and administrative expenses, and capital expenditures post-merger, which will enhance overall operational efficiency and profitability.
- Regulatory Review Progress: While the merger has been approved in the U.S., both companies are still engaging with the U.K. Competition and Markets Authority, hoping to secure final approval by April 19 to ensure a smooth merger process globally.
See More
Kraig Biocraft Laboratories Featured on National Geographic Cover
- Technological Breakthrough: Kraig Biocraft Laboratories' recombinant spider silk technology featured on the cover of National Geographic, showcasing its genetically enhanced silkworm platform, is expected to drive stock price appreciation and attract investor interest.
- Production Scale: The company plans to deploy approximately one million proprietary silkworm eggs in Vietnam, targeting up to 10 metric tons of cocoons per month, which would make KBLB only the second company in history to achieve sustained commercial production from a transgenic animal platform.
- Market Potential: With confirmation of initial deliveries to global brand partners, KBLB is poised to transition from a research narrative to a specialty materials platform, further solidifying its position in the luxury fashion and performance sportswear markets.
- Acquisition Dynamics: Gilead Sciences announced the acquisition of Arcellx for $115 per share, totaling approximately $7.8 billion, which further consolidates its oncology market position and may enhance the acceptance of related therapies.
See More
CMA in the UK Announces 18 March Deadline for Comments on Remedies in Getty Images/Shutterstock Deal, Including Alternative Options
Deadline for Comments: The UK’s CMA has set a deadline of March 18 for any comments on remedies related to the ongoing investigation.
Focus on Alternative Remedies: The investigation includes considerations for alternative remedies in the context of the case.
See More
UK's CMA Announces Extension of Reference Period for Getty Images/Shutterstock Deal to June 14, 2026
UK's CMA Inquiry Group: The UK's Competition and Markets Authority (CMA) has decided to extend the reference period for its inquiry.
New Deadline: The new deadline for the inquiry has been set to June 14, 2026.
See More
Canva Acquires Startups to Counter Market Challenges
- Acquisition Strategy: Canva's acquisition of startups Cavalry and MangoAI aims to bolster its competitive edge in animation and short video advertising, particularly as Adobe faces market pressures, demonstrating Canva's proactive approach to market changes.
- Technology Integration: Cavalry's animation technology will be integrated into Canva's core products and the Affinity application, enhancing user capabilities in motion graphics while allowing Cavalry to operate independently to meet diverse designer needs.
- Revenue Growth: Canva reported an annualized revenue exceeding $4 billion in 2025, a 36% increase year-over-year, indicating strong growth momentum in a competitive market, despite Adobe's market capitalization reaching $101 billion.
- AI Application Prospects: Canva plans to incorporate MangoAI technology into its Canva Grow advertisement generator, assisting users in analyzing video performance and optimizing content strategies, further enhancing product competitiveness and user experience.
See More
U.S. DOJ Approves Getty Images and Shutterstock Merger
- Merger Approval: The U.S. Department of Justice has approved the $3.7 billion merger proposal between Getty Images and Shutterstock, marking a significant advancement in their global market consolidation that is expected to enhance their competitive positioning.
- Waiting Period Expiration: The applicable waiting period under the Hart-Scott Rodino Act has expired, allowing the two companies to begin merger preparations ahead of the final decision from the UK's Competition and Markets Authority (CMA).
- Market Reaction: Although the merger news initially boosted the stock prices of both companies, Getty Images has now experienced its eighth consecutive day of decline, while Shutterstock's shares have also dipped slightly, indicating market caution regarding the merger's prospects.
- Future Outlook: In a joint statement, both companies expressed optimism regarding the CMA's final decision, hoping it will align with the DOJ and other global regulators, based on the merits of the transaction and market realities.
See More
Getty Images Merger with Shutterstock Cleared by DOJ
- Merger Approval: The U.S. Department of Justice has cleared the merger proposal between Getty Images and Shutterstock, marking a significant step towards resource integration and strengthening financial foundations, which is expected to create more investment opportunities in the future.
- Stock Surge: Following the merger announcement, Getty's stock price soared by 32.96% to 98 cents per share, reflecting strong market optimism about the merger's prospects and potentially attracting more investor interest.
- Expected Synergies: The companies anticipate achieving substantial synergies in sales, general and administrative expenses, and capital expenditures post-merger, which will enhance overall operational efficiency and profitability.
- Regulatory Review Progress: While the merger has been approved in the U.S., both companies are still engaging with the U.K. Competition and Markets Authority, hoping to secure final approval by April 19 to ensure a smooth merger process globally.
See More
Kraig Biocraft Laboratories Featured on National Geographic Cover
- Technological Breakthrough: Kraig Biocraft Laboratories' recombinant spider silk technology featured on the cover of National Geographic, showcasing its genetically enhanced silkworm platform, is expected to drive stock price appreciation and attract investor interest.
- Production Scale: The company plans to deploy approximately one million proprietary silkworm eggs in Vietnam, targeting up to 10 metric tons of cocoons per month, which would make KBLB only the second company in history to achieve sustained commercial production from a transgenic animal platform.
- Market Potential: With confirmation of initial deliveries to global brand partners, KBLB is poised to transition from a research narrative to a specialty materials platform, further solidifying its position in the luxury fashion and performance sportswear markets.
- Acquisition Dynamics: Gilead Sciences announced the acquisition of Arcellx for $115 per share, totaling approximately $7.8 billion, which further consolidates its oncology market position and may enhance the acceptance of related therapies.
See More
